MOMA-341

N/A

Report date: 2025/05/16 20:00:39
NME

Base Information

Drug NameMOMA-341
Drug Alias NameMOMA-341
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBifunctional 3'-5' exonuclease/ATP-dependent helicase WRN inhibitors
TargetsBifunctional 3'-5' exonuclease/ATP-dependent helicase WRN
Therapy Area/IndicationsSolid tumoursMicrosatellite instability-high cancerMismatch Repair Deficient Cancer +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesMoma Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesMoma Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursMicrosatellite instability-high cancerMismatch Repair Deficient Cancer +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A